Posted inBusiness

Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials

April 7, 2022No Comments

Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.

Pam Belluck
Author: Pam Belluck

Last updated on April 7, 2022

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.